Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation

NCT01687257 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C
Cirrhosis
Portal Hypertension
With or Without Liver Decompensation

Interventions

DRUG: SOF
DRUG: RBV

Sponsor

Gilead Sciences